0001213900-22-021403.txt : 20220425
0001213900-22-021403.hdr.sgml : 20220425
20220425162528
ACCESSION NUMBER: 0001213900-22-021403
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220422
FILED AS OF DATE: 20220425
DATE AS OF CHANGE: 20220425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grauch Edward Rowland
CENTRAL INDEX KEY: 0001757536
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14120
FILM NUMBER: 22850000
MAIL ADDRESS:
STREET 1: 3208 HIGHWAY 98
CITY: MEXICO BEACH
STATE: FL
ZIP: 32456
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BLONDER TONGUE LABORATORIES INC
CENTRAL INDEX KEY: 0001000683
STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
IRS NUMBER: 521611421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE JAKE BROWN RD
STREET 2: PO BOX 1000
CITY: OLD BRIDGE
STATE: NJ
ZIP: 08857
BUSINESS PHONE: 9086794000
MAIL ADDRESS:
STREET 1: ONE JAKE BROWN ROAD
CITY: OLD BRIDGE
STATE: NJ
ZIP: 08857
4
1
ownership.xml
X0306
4
2022-04-22
0
0001000683
BLONDER TONGUE LABORATORIES INC
BDR
0001757536
Grauch Edward Rowland
C/O BLONDER TONGUE LABORATORIES, INC.
ONE JAKE BROWN ROAD
OLD BRIDGE
NJ
08857
0
1
0
0
CEO & President
Common Stock, par value $0.001
2022-04-22
4
A
0
1505
0.69
A
414347
D
Common Stock, par value $0.001
2022-04-22
4
A
0
6773
0.69
A
421120
D
Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).
Pursuant to the participation in the Second Amended and Restated Executive Stock Purchase Plan between the reporting person and the issuer, on the date on which a portion of the reporting person's net cash compensation has been reduced, the issuer issued the number of shares indicated. The number of shares of common stock issued represents the quotient of (i) the portion of the net cash compensation reduction divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the NYSE American on such date).
/s/ Edward R. Grauch by Eric Skolnik Under Power of Attorney
2022-04-25